CAS 26308-28-1

Ripazepam

Description:

Ripazepam is a chemical compound classified as a benzodiazepine derivative, primarily known for its anxiolytic and sedative properties. It is often utilized in the treatment of anxiety disorders and has been studied for its potential effects on sleep and muscle relaxation. The molecular structure of Ripazepam features a benzodiazepine core, which is characterized by a fused benzene and diazepine ring, contributing to its pharmacological activity. The compound exhibits a relatively high affinity for GABA-A receptors, enhancing the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) effects in the central nervous system. This mechanism underlies its therapeutic effects, including anxiolysis and sedation. Ripazepam is typically administered in oral form, and its pharmacokinetics may involve metabolism in the liver, with potential variations in half-life and bioavailability among individuals. As with other benzodiazepines, caution is advised regarding dependence and withdrawal symptoms with prolonged use. Overall, Ripazepam represents a significant option in the pharmacological management of anxiety and related conditions.

Formula: C₁₅H₁₆N₄O

InChI: InChI=1S/C15H16N4O/c1-3-19-15-13(10(2)18-19)17-12(20)9-16-14(15)11-7-5-4-6-8-11/h4-8H,3,9H2,1-2H3,(H,17,20)

InChI key: InChIKey=YFHYNLHGFKXAIQ-UHFFFAOYSA-N

SMILES: C(C)N1C=2C(=NCC(=O)NC2C(C)=N1)C3=CC=CC=C3

Synonyms:

• 1-Ethyl-4,6-dihydro-3-methyl-8-phenylpyrazolo[4,3-e][1,4]diazepin-5(1H)-one
• Pyrazolo[4,3-e][1,4]diazepin-5(1H)-one, 1-ethyl-4,6-dihydro-3-methyl-8-phenyl-
• Cl 683
• Ripazepam
• Pyrazapon

Ripazepam

CAS: 26308-28-1

Ripazepam has anxiolytic effects.

Formula: C₁₅H₁₆N₄O

Color and Shape: Solid

Molecular weight: 268.31

Ref: TM-T28539